The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
about
Distinct genealogies for plasmids and chromosomeEscherichia coli β-Lactamases: What Really MattersFluoroquinolone-Resistant Enteric Bacteria in Sub-Saharan Africa: Clones, Implications and Research NeedsMolecular Characterization of the Multidrug Resistant Escherichia coli ST131 CloneA new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131Population-based epidemiology and microbiology of community-onset bloodstream infectionsGlobal Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 GeneEvaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in SwedenCombined Analysis of Variation in Core, Accessory and Regulatory Genome Regions Provides a Super-Resolution View into the Evolution of Bacterial PopulationsThe role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing.Genomic and Functional Portrait of a Highly Virulent, CTX-M-15-Producing H30-Rx Subclone of Escherichia coli Sequence Type 131.Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.Biofilm formation by multidrug resistant Escherichia coli ST131 is dependent on type 1 fimbriae and assay conditions.The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.Comprehensive analysis of type 1 fimbriae regulation in fimB-null strains from the multidrug resistant Escherichia coli ST131 clone.Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.Comparative Genome Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type 131 Strains from Nepal and JapanPopulation structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance.Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.Rapid Identification of Different Escherichia coli Sequence Type 131 Clades.Urinary tract infections attributed to diverse ExPEC strains in food animals: evidence and data gaps.Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.Emerging sporotrichosis is driven by clonal and recombinant Sporothrix species.Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage.Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012).Genomic interplay in bacterial communities: implications for growth promoting practices in animal husbandry.Escherichia coli ST131, an intriguing clonal groupGlobal incidence of carbapenemase-producing Escherichia coli ST131.Clinical and molecular epidemiology of Escherichia coli sequence type 131 among hospitalized patients colonized intestinally with fluoroquinolone-resistant E. coli.Molecular features of community-associated extended-spectrum-β-lactamase-producing Escherichia coli strains in the United States.Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012.Within-population distribution of trimethoprim resistance in Escherichia coli before and after a community-wide intervention on trimethoprim useGenotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India.Plasmid flux in Escherichia coli ST131 sublineages, analyzed by plasmid constellation network (PLACNET), a new method for plasmid reconstruction from whole genome sequences.Current and emerging Legionella diagnostics for laboratory and outbreak investigations.Molecular characterization of blaNDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in SpainAntibiotic-resistant gram-negative bacterial infections in patients with cancer.Large-scale genomic sequencing of extraintestinal pathogenic Escherichia coli strains.
P2860
Q21092398-FCD9263C-CCFD-49E8-8BC5-70EEEBB99EA8Q26749590-856CDB2C-F338-4B82-8D2D-124EC20F8551Q26752573-98EF9C68-25B7-4412-AC37-080317D4FB0AQ27000929-D1E466CF-8410-4A03-A25C-EE12A6326F35Q27011287-EBDDAC2E-31CF-42C0-BD53-76909448C797Q27013639-01A8F7D0-E650-4122-8378-5B2183A9467CQ28112087-6EC34A0B-FA08-4182-837D-DFE2F01F48A2Q28365034-92585DE7-0E7B-47D5-A3DB-65F02C212057Q28554017-279C93A5-CE08-4B57-8247-0AB3F77F9482Q30300020-E56650D0-39AA-4399-9C35-E7E082ACD558Q30301008-7B71FD08-74F4-4BBA-9F60-EB344079081DQ30376979-69B3FA60-E0EB-4906-A023-ACB7EAD840DAQ30378612-EF029BB4-8C5D-443B-8978-86F3833F480AQ30385226-96821337-7795-4AC0-8968-96AAF51B7303Q30386217-1AB5D733-5901-4C21-ABA1-BD68A3951C9FQ30389375-25A1194F-B2F6-4D5F-89D0-B13C37E1EE52Q30393531-B2977679-5D28-457A-90C1-B31E21DAEC98Q30395087-C1ACE624-D746-4DDD-AED2-C8097A6388A5Q30397339-74F4702A-3D87-4611-A333-7881CDFF8658Q30401332-ACF22B9E-648A-4E28-B047-0CC0342B5CBBQ30402760-E6B7B76B-8A56-4463-B46E-AA52F0EBFAF0Q30896253-79E8389A-37C6-492E-A949-F8AF3E50DE65Q33706348-3AE5EE33-6D35-4849-8F36-5F45EC36A904Q33733015-914B7196-399B-4C65-B26B-DA099B2EF957Q33798233-11169C47-2A4E-48C7-A96C-BE27AA077B60Q33798438-EAB717C8-A162-42F0-B818-E5944D264839Q33806382-5303EC2C-4F51-4605-AE24-E266DF9CCA90Q34031581-6E33D75F-F2A5-4C07-B2F6-0DADDAF477D7Q34057648-1E4007D2-5BD4-43CC-A7BB-3E8FE3AF0965Q34426812-3229EE77-A1A5-4E6C-9AF5-BA3535E47EDDQ34596560-9BA436D3-6BC6-4FE5-9F6F-6862C79CCF56Q34596687-B1012B46-7921-49E3-8AE8-AF91B1C3DE3CQ34596717-26B5AB03-3C34-4403-9FFF-DCBA283F1D1EQ34597729-35DF1012-7905-4A2F-B2E8-9A4C4D77580AQ34597880-C384EEA8-9854-4D00-8AA2-BAED13DB2B5EQ34732534-3B348134-F048-4B95-8E37-EEC22325FDF7Q34826656-6C9BCAD5-5152-4268-A0B5-21813311C980Q34923066-88AD0D8E-A96D-4DB9-A95A-91E6FF7F2908Q34999880-FCD1B885-DD4D-4B1F-B3C3-916EC3D9B443Q35049379-69A4D12B-3217-4659-ACCF-F4767B92CCE3
P2860
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The epidemic of extended-spect ...... y pathogenic subclone, H30-Rx.
@en
The epidemic of extended-spect ...... y pathogenic subclone, H30-Rx.
@nl
type
label
The epidemic of extended-spect ...... y pathogenic subclone, H30-Rx.
@en
The epidemic of extended-spect ...... y pathogenic subclone, H30-Rx.
@nl
prefLabel
The epidemic of extended-spect ...... y pathogenic subclone, H30-Rx.
@en
The epidemic of extended-spect ...... y pathogenic subclone, H30-Rx.
@nl
P2093
P2860
P50
P356
P1433
P1476
The epidemic of extended-spect ...... y pathogenic subclone, H30-Rx.
@en
P2093
Brian Johnston
Connie Clabots
Delia Scholes
Evgeni V Sokurenko
Kim Riddell
Lance B Price
Lora Nordstrom
Maliha Aziz
Maria Billig
P2860
P304
P356
10.1128/MBIO.00377-13
P577
2013-12-17T00:00:00Z